Surrogate endpoints provide no guarantee of clinical benefit, and the authors argue they should be used only as a last resort in drug trials.
Raising the bar for using surrogate endpoints in drug regulation and health technology assessment
Ciani, Oriana;
2021
Abstract
Surrogate endpoints provide no guarantee of clinical benefit, and the authors argue they should be used only as a last resort in drug trials.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Raising the bar for using surrogate endpoints in drug regulation and health technology assessment.pdf
accesso aperto
Descrizione: articolo
Tipologia:
Pdf editoriale (Publisher's layout)
Licenza:
PUBBLICO DOMINIO
Dimensione
739.4 kB
Formato
Adobe PDF
|
739.4 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
